Myriad Genetics Inc. Q2 Income Advances

Myriad Genetics Inc. (MYGN) released earnings for its second quarter that gained ground from last year.

The company said its bottom line came in at $22.3 million, or $0.31 per share. This was higher than $17.5 million, or $0.26 per share, in last year's second quarter.

Analysts had expected the company to earn $0.24 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 1.3% to $194.0 million. This was down from $196.5 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q2): $22.3 Mln. vs. $17.5 Mln. last year.
-Earnings Growth (Y-o-Y): 27.4%
-EPS (Q2): $0.31 vs. $0.26 last year.
-EPS Growth (Y-o-Y): 19.2%
-Analysts Estimate: $0.24
-Revenue (Q2): $194.0 Mln vs. $196.5 Mln last year.
-Revenue Change (Y-o-Y): -1.3%

Next quarter EPS guidance: $0.26-$0.28
Next quarter revenue guidance: $186-$188 Mln
Full year EPS guidance: $1.11-$1.16
Full year revenue guidance: $760-$770 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT